FRANKFURT, Germany -- BioNTech's chief executive reassured Japan on Tuesday that the German drugmaker can deliver its COVID-19 vaccine soon after the inoculation receives approval from Tokyo, which is expected as early as mid-February.
"We are confident that we will deliver the doses that we have promised to Japan," CEO Ugur Sahin said in an online news conference.
